Patents by Inventor Pawel T. Dobrzanski

Pawel T. Dobrzanski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF MULTIPLE SCLEROSIS WITH A 1,2,4-TRIAZOLO [1,5A] PYRIDINE DERIVATIVE
    Publication number: 20160303116
    Abstract: The present disclosure provides methods and compositions for treating chronic autoimmune diseases, such as multiple sclerosis, using [8-(4-methanesulfonyl-phenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl]-[3-(4-methyl-piperazin-1-yl)-phenyl]-amine or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: December 10, 2014
    Publication date: October 20, 2016
    Inventors: Pawel T. DOBRZANSKI, Joel KAYE, Arie ORBACH, Bruce A. RUGGERI, Matthew M. SEAVEY
  • Treatment of chronic inflammation with a 1,2,4-triazolo [1,5a] pyridine derivative
    Patent number: 9034876
    Abstract: This application describes and provides a method of treating diseases or disorders characterized by chronic systemic inflammation, such as rheumatoid arthritis, using a compound that inhibits JAK2 kinase.
    Type: Grant
    Filed: June 6, 2013
    Date of Patent: May 19, 2015
    Assignee: Cephalon, Inc.
    Inventors: Pawel T. Dobrzanski, Matthew M. Seavey
  • Janus kinase 2 (JAK2) inhibitor for the treatment of lupus
    Patent number: 9023853
    Abstract: The present invention provides a method for treating lupus in a subject, comprising the step of administering to the subject COMPOUND A.
    Type: Grant
    Filed: June 6, 2013
    Date of Patent: May 5, 2015
    Assignee: Cephalon, Inc.
    Inventors: Pawel T. Dobrzanski, Matthew M. Seavey
  • JANUS KINASE 2 (JAK2) INHIBITOR FOR THE TREATMENT OF LUPUS
    Publication number: 20140024655
    Abstract: The present invention provides a method for treating lupus in a subject, comprising the step of administering to the subject COMPOUND A
    Type: Application
    Filed: June 6, 2013
    Publication date: January 23, 2014
    Applicant: Cephalon, Inc.
    Inventors: Pawel T. Dobrzanski, Matthew M. Seavey
  • Treatment of Chronic Inflammation with a 1,2,4-Triazolo [1,5a] Pyridine Derivative
    Publication number: 20130267535
    Abstract: This application describes and provides a method of treating diseases or disorders characterized by chronic systemic inflammation, such as rheumatoid arthritis, using a compound that inhibits JAK2 kinase.
    Type: Application
    Filed: June 6, 2013
    Publication date: October 10, 2013
    Inventors: Pawel T. Dobrzanski, Matthew M. Seavey